These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10400149)

  • 1. Control of low-level radiation exposure: time for a change?
    Clarke R
    J Radiol Prot; 1999 Jun; 19(2):107-15. PubMed ID: 10400149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of low-level radiation exposure: what is the problem and how can it be solved?
    Clarke RH
    Health Phys; 2001 Apr; 80(4):391-6. PubMed ID: 11281209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in the control of low-level radiation exposure.
    Clarke RH
    Med Confl Surviv; 2000; 16(4):411-22. PubMed ID: 11130633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A report on progress towards new recommendations: a communication from the International Commission on Radiological Protection.
    International Commission on Radiological Protection.
    J Radiol Prot; 2001 Jun; 21(2):113-23. PubMed ID: 11430512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles of the International Commission on Radiological Protection system of dose limitation.
    Thorne MC
    Br J Radiol; 1987 Jan; 60(709):32-8. PubMed ID: 3814995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICRP comes up trumps.
    Webb G
    J Radiol Prot; 2006 Sep; 26(3):251-2. PubMed ID: 16926467
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of the ICRP recommendations to revised secondary radiation protection standards.
    Kennedy WE; Corley JP
    Health Phys; 1988 Aug; 55(2):427-31. PubMed ID: 3410714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The debate on the use of linear no threshold for assessing the effects of low doses.
    Tubiana M; Aurengo A; Averbeck D; Masse R
    J Radiol Prot; 2006 Sep; 26(3):317-24. PubMed ID: 16926474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNT--an apparent rather than a real controversy?
    Charles MW
    J Radiol Prot; 2006 Sep; 26(3):325-9. PubMed ID: 16926475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Effects From Low Doses and Dose Rates of Ionizing Radiation: Science in the Service of Protecting Humans, a Synopsis.
    Feinendegen LE; Cuttler JM
    Health Phys; 2018 Jun; 114(6):623-626. PubMed ID: 29521814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (w(R)). A report of the International Commission on Radiological Protection.
    Task Group on Radiation Quality Effects in Radiological Protection, Committee 1 on Radiation Effects, International Commission on Radiological Protection
    Ann ICRP; 2003; 33(4):1-117. PubMed ID: 14614921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Principal inferences from studies of radiobiological effects for radiation protection purposes].
    Akleev AV
    Radiats Biol Radioecol; 2011; 51(5):501-11. PubMed ID: 22279763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New ICRP recommendations.
    Wrixon AD
    J Radiol Prot; 2008 Jun; 28(2):161-8. PubMed ID: 18495983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations of the International Commission on Radiological Protection (ICRP) 1990.
    Mountford PJ; Temperton DH
    Eur J Nucl Med; 1992; 19(2):77-9. PubMed ID: 1563443
    [No Abstract]   [Full Text] [Related]  

  • 15. Radar commentary: Use of linear no-threshold hypothesis in radiation protection regulation in the United States.
    Siegel JA; Stabin MG
    Health Phys; 2012 Jan; 102(1):90-9. PubMed ID: 22134084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of ICRP Committee 1: radiation effects.
    Morgan WF
    Ann ICRP; 2016 Jun; 45(1 Suppl):9-16. PubMed ID: 26635336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation protection recommendations on dose limits: the role of the NCRP and the ICRP and future developments.
    Sinclair WK
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):387-92. PubMed ID: 7836093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying radiation risks.
    Smith H
    Radiat Prot Dosimetry; 1999; 86(4):259-62. PubMed ID: 11543394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective dose from radiopharmaceuticals.
    Johansson L; Mattsson S; Nosslin B; Leide-Svegborn S
    Eur J Nucl Med; 1992; 19(11):933-8. PubMed ID: 1308762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the draft 2005 recommendations of ICRP on secondary derived regulatory values being considered by the US Department of Energy.
    O'Connell P
    Radiat Prot Dosimetry; 2006; 118(1):97-101. PubMed ID: 16105895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.